Education
About Us
Working with TipRanks
Follow Us
Quantum-Si (QSI)
NASDAQ:QSI
QSI Stock Chart & Stats
$1.07
-$0.96(-27.61%)
At close: 4:00 PM EST
$1.07
-$0.96(-27.61%)
Day’s Range― - ―
52-Week Range$0.92 - $3.10
Previous CloseN/A
Volume35.47M
Average Volume (3M)4.97M
Market Cap
$230.57M
Enterprise Value$176.10M
Total Cash (Recent Filing)$225.84M
Total Debt (Recent Filing)$4.61M
Price to Earnings (P/E)―
Beta2.75
Next Earnings
Mar 03, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding195,552,170
10 Day Avg. Volume5,246,818
30 Day Avg. Volume4,972,235
Financial Highlights & Ratios
PEG Ratio-0.87
Price to Book (P/B)1.79
Price to Sales (P/S)126.43
P/FCF Ratio-4.19
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue55.43
Enterprise Value/Gross Profit107.31
Enterprise Value/Ebitda-1.55
Forecast
1Y Price Target
$2.67Price Target Upside149.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Instrument PerformancePlatform improvements deliver higher alignment rates per well, longer read lengths, and improved signal-to-noise, which can increase sequencing accuracy and sample throughput.
Proteomics Capability And PTM DetectionProteus' single-molecule approach and planned methods for comprehensive amino acid coverage and post-translational modification detection promise direct counting, simplified workflows, and more precise modification site identification than mass spectrometry.
Scalability And Market ExpansionKinetIQ Array architecture with millions of wells per device and a roadmap to scale capacity supports lower per-sample costs and expansion into broader protein sequencing markets.
Bears Say
Commercialization And Funding RiskPersistent reductions in NIH funding create headwinds for commercializing instruments and could slow placement rates and customer adoption.
Market Demand UncertaintyUnclear demand and limited defined applications for protein sequencing may restrain adoption beyond early research users and limit revenue growth.
Sales Performance Of Current SystemsPlatinum instrument sales falling short of expectations weakens near-term revenue visibility and raises reliance on future product launches to drive growth.
Quantum-Si News
QSI FAQ
What was Quantum-Si’s price range in the past 12 months?
Quantum-Si lowest stock price was $0.92 and its highest was $3.10 in the past 12 months.
What is Quantum-Si’s market cap?
Quantum-Si’s market cap is $230.57M.
When is Quantum-Si’s upcoming earnings report date?
Quantum-Si’s upcoming earnings report date is Mar 03, 2026 which is in 18 days.
How were Quantum-Si’s earnings last quarter?
Quantum-Si released its earnings results on Nov 05, 2025. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of -$0.133 by -$0.037.
Is Quantum-Si overvalued?
According to Wall Street analysts Quantum-Si’s price is currently Undervalued.
Does Quantum-Si pay dividends?
Quantum-Si does not currently pay dividends.
What is Quantum-Si’s EPS estimate?
Quantum-Si’s EPS estimate is -0.12.
How many shares outstanding does Quantum-Si have?
Quantum-Si has 195,552,170 shares outstanding.
What happened to Quantum-Si’s price movement after its last earnings report?
Quantum-Si reported an EPS of -$0.17 in its last earnings report, missing expectations of -$0.133. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Quantum-Si?
Currently, no hedge funds are holding shares in QSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Quantum-Si Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.67 (149.53% Upside)
$2.67 (149.53% Upside)
Blogger Sentiment
Neutral
QSI Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 336.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $84.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 11.3%
Last 30 Days ▼ 11.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.54%
12-Months-Change
Fundamentals
Return on Equity
-52.44%
Trailing 12-Months
Asset Growth
10.01%
Trailing 12-Months
Company Description
Quantum-Si
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
QSI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted significant advancements in product development and strategic placements in academic institutions, despite financial challenges due to market conditions and a costly lease termination. The focus on innovation and cost management was balanced against the impact of external funding uncertainties.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$2.67
▲(149.53% Upside)
Technical Analysis
Ownership Overview
21.54% Insiders
6.44% Mutual Funds
0.03% Other Institutional Investors
59.79% Public Companies and
Individual Investors